These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10926007)

  • 1. Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel disease.
    Bantel H; Domschke W; Schulze-Osthoff K; Kaskas B; Gregor M
    Am J Gastroenterol; 2000 Jul; 95(7):1845-6. PubMed ID: 10926007
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of AP-1 and NF-kappaB in glucocorticoid resistance].
    Okabe T; Yanase T; Nawada H
    Nihon Rinsho; 2005 Sep; 63(9):1654-9. PubMed ID: 16164226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease: treatment postulates and future prospects.
    Saeed SA; Zaidi AH
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):197. PubMed ID: 18460258
    [No Abstract]   [Full Text] [Related]  

  • 4. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
    Egan LJ; Toruner M
    Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease.
    Nikolaus S; Fölscn U; Schreiber S
    Hepatogastroenterology; 2000; 47(31):71-82. PubMed ID: 10690587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of glucocorticoid receptor signaling during inflammation.
    Smoak KA; Cidlowski JA
    Mech Ageing Dev; 2004; 125(10-11):697-706. PubMed ID: 15541765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor signaling in the intestinal epithelial cell lines IEC-6 and Caco-2: evidence of inhibition by interleukin-1beta.
    Raddatz D; Toth S; Schwörer H; Ramadori G
    Int J Colorectal Dis; 2001 Nov; 16(6):377-83. PubMed ID: 11760899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid sensitivity in inflammatory bowel disease.
    Sidoroff M; Kolho KL
    Ann Med; 2012 Sep; 44(6):578-87. PubMed ID: 21992564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
    Meduri GU; Yates CR
    Ann N Y Acad Sci; 2004 Jun; 1024():24-53. PubMed ID: 15265772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gut feeling of the PXR, PPAR and NF-kappaB connection.
    Wahli W
    J Intern Med; 2008 Jun; 263(6):613-9. PubMed ID: 18479261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells.
    Dvorák Z; Vrzal R; Maurel P; Ulrichová J
    Chem Biol Interact; 2006 Feb; 159(2):117-28. PubMed ID: 16289013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of steroid-resistant asthma.
    Lane SJ
    Br J Hosp Med; 1997 Apr 16-May 6; 57(8):394-8. PubMed ID: 9296792
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
    Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
    Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappa B in intestinal protection and destruction.
    Spehlmann ME; Eckmann L
    Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear transcription factor NF-kappa B: role in biology and medicine.
    Aggarwal BB; Takada Y; Shishodia S; Gutierrez AM; Oommen OV; Ichikawa H; Baba Y; Kumar A
    Indian J Exp Biol; 2004 Apr; 42(4):341-53. PubMed ID: 15088683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complicated path to true causes of disease: role of nuclear factor kappaB in inflammatory bowel disease.
    Schreiber S
    Gut; 2005 Apr; 54(4):444-5. PubMed ID: 15753521
    [No Abstract]   [Full Text] [Related]  

  • 19. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.
    Webster JC; Oakley RH; Jewell CM; Cidlowski JA
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6865-70. PubMed ID: 11381138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory bowel disease--the role and issue of glucocorticoid].
    Ashida T
    Nihon Rinsho; 2008 Jan; 66(1):137-41. PubMed ID: 18186257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.